soul trial oral semaglutide cardiovascular outcomes 2024 nejm reduced the risk of clinically important kidney and death from (CV) causes in patients with type 2 diabetes (T2D) and CKD ca. #ERA24 🇸🇪 #Nephpearls https://www.nejm .org/doi/full/10.1056/NEJMoa2403347 NEJM Editorial Fellow Harleen Marwah,

How do I know if my body handles early injections well or poorly

This is what the future of weight-loss and wellness clinics and chains in India looks like for those who qualify for medically assisted weight loss

Adding imprecise numbers will give you an imprecise total

"We know that every consumer on a health journey has individualized needs and considerations, and having options to support those needs will continue to play an important role," said Tom Moe, President, Nestl USA Meals Division

This weight regain occurs because the medications appetite-suppressing effects and reduction in "food noise" diminish within five to seven weeks after the last dose